胸部CT稳定5年后6毫米及以上亚实性结节的生长及临床影响
本回顾性研究评估235例患者235个稳定5年的6毫米及以上肺亚实性结节,中位随访112个月,仅5个(2%)出现间期生长,其中3个发生临床分期偏移,随访期间无肺癌相关死亡或转移;作者结论认为稳定5年后生长率低且无临床影响。
要点
- 稳定5年的6毫米及以上亚实性结节中仅2%后续生长,多与10毫米及以上病灶相关。
- 生长的5个结节中3个出现Tis至T1mi或T1mi至T1a的临床分期偏移。
- 随访期间无肺癌相关死亡或转移,生长未产生临床影响。
核心结论
- 稳定5年的6毫米及以上肺亚实性结节中仅2%出现后续生长,中位随访9年期间生长无临床影响。
研究设计与样本
- 回顾性研究,纳入2002年1月至2018年12月检出后稳定5年的6毫米及以上亚实性结节,共235个结节(235例患者,平均年龄64岁±10岁,132例女性)。
- 结节包括212个纯磨玻璃结节和24个部分实性结节,随访中位112个月(范围84-208个月)。
- 对160个采用层厚≤1.5毫米非增强薄层CT成像的结节进行亚组分析。
关键影像表现/征象
- 235个结节中5个(2%)出现间期生长,包括3个原发性磨玻璃结节和2个部分实性结节。
- 5个生长结节中3个直径≥10毫米。
- 薄层CT(层厚≤1.5毫米)亚组160个结节中2个(1%)生长,均为直径≥10毫米的病灶。
临床应用与阅片要点
- 对于稳定5年的6毫米及以上亚实性结节,后续生长率低,随访中可关注直径≥10毫米的病灶。
- 生长的结节可出现临床分期偏移(Tis至T1mi、T1mi至T1a),但随访期间无肺癌相关死亡或转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background It remains unclear whether 5 years of stability is sufficient to establish the benign behavior of subsolid nodules (SSNs) of the lung. There are no guidelines for the length of follow-up needed for these SSNs. Purpose To investigate the incidence of interval growth of pulmonary SSNs 6 mm or greater in diameter after 5 years of stability and their clinical outcome. Materials and Methods This retrospective study assessed SSNs 6 mm or greater that were stable for 5 years after detection (January 2002 to December 2018). The incidence of interval growth after 5 years of stability and the clinical and radiologic features of these SSNs were investigated. Clinical stage shifts of growing SSNs, presence of metastasis, and overall survival were assessed during the follow-up period. Subgroup analysis was performed in patients with nonenhanced thin-section (section thickness ≤1.5 mm) CT for interval growth after 5 years of stability. Results A total of 235 SSNs in 235 patients (mean age, 64 years ± 10 [standard deviation]; 132 women) were evaluated. There were 212 pure ground-glass nodules and 24 part-solid nodules. During follow-up (median, 112 months; range, 84-208 months), five of the 235 SSNs (2%; three primary ground-glass nodules and two part-solid nodules) showed interval growth. Three of these five growing SSNs were 10 mm or greater. Three of the five SSNs with interval growth had clinical stage shifts after growth (from Tis [in situ] to T1mi [minimally invasive] in one lesion; from T1mi to T1a in two lesions). There were no deaths or metastases from lung cancer during follow-up. Of 160 SSNs imaged with section thickness of 1.5 mm or less, two (1%) grew; both lesions were 10 mm or greater. Conclusion Only 2% of subsolid pulmonary nodules greater than or equal to 6 mm that had been stable for 5 years showed subsequent growth. At median follow-up of 9 years (after the initial 5-year period of stability), growth of those lung nodules had no clinical effect. © RSNA, 2020 See also the editorial by Naidich and Azour in this issue.
引用
- Lee JH, Lim WH, Hong JH, et al. Growth and Clinical Impact of 6-mm or Larger Subsolid Nodules after 5 Years of Stability at Chest CT. Radiology. 2020. PMID: 32181731. doi:10.1148/radiol.2020191921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。